10,451 Shares of Maximus, Inc. $MMS Purchased by Vise Technologies Inc.

Vise Technologies Inc. bought a new position in Maximus, Inc. (NYSE:MMS) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,451 shares of the health services provider’s stock, valued at approximately $556,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MMS. Empowered Funds LLC bought a new stake in Maximus in the 2nd quarter worth approximately $504,000. Squarepoint Ops LLC boosted its position in shares of Maximus by 723.0% during the 2nd quarter. Squarepoint Ops LLC now owns 219,301 shares of the health services provider’s stock valued at $11,790,000 after acquiring an additional 192,655 shares during the last quarter. Hsbc Holdings PLC bought a new position in shares of Maximus during the 2nd quarter valued at approximately $956,000. Corient Private Wealth LP bought a new position in shares of Maximus during the 2nd quarter valued at approximately $1,984,000. Finally, Legal & General Group Plc purchased a new position in shares of Maximus in the second quarter valued at $4,488,000. 97.21% of the stock is owned by institutional investors.

Insider Activity at Maximus

In other news, insider Michelle Link sold 3,208 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $54.23, for a total transaction of $173,969.84. Following the transaction, the insider owned 13,881 shares of the company’s stock, valued at approximately $752,766.63. The trade was a 18.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Maximus in a research report on Monday, August 17th. Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Zacks Research upgraded shares of Maximus from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 1st. Two research analysts have rated the stock with a Hold rating. According to MarketBeat, Maximus currently has an average rating of “Hold”.

Maximus Trading Down 1.1%

Shares of NYSE MMS opened at $65.37 on Thursday. The business’s 50 day moving average is $59.20 and its two-hundred day moving average is $63.89. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. Maximus, Inc. has a 1-year low of $51.04 and a 1-year high of $100.00. The stock has a market capitalization of $3.42 billion, a P/E ratio of 9.66 and a beta of 0.57.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be issued a $0.33 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. Maximus’s payout ratio is 19.50%.

Maximus Profile

Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.